Recently, Shanghai Kongshan Ci Technology Co., Ltd., a firm dedicated to the cutting-edge fields of next-generation brain-computer interaction and neuromodulation technology, has officially declared the successful closure of its Series A financing round.
This financing endeavor was spearheaded by Orient Fortune Capital, with significant contributions from Glory Ventures. Furthermore, the company received ongoing support from its existing shareholders, namely Daotong Capital and Yunqi Partners. Capital Peak Partners played a pivotal role as the financial advisor throughout this process.
The capital raised in this round will be predominantly allocated towards product research and development, with a focus on iterative improvements, securing medical device registrations, and fueling the company's global expansion initiatives.
